First DTC Test for Some BRCA Mutations Authorized by FDA

The first direct-to-consumer test specifically for BRCA1/2 mutations has been authorized by the FDA.
FDA Approvals

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply